IMPAVIDO (Paladin Therapeutics Inc.)
Welcome to the PulseAid listing for the IMPAVIDO drug offered from Paladin Therapeutics Inc.. This Antileishmanial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Paladin Therapeutics Inc. |
| NON-PROPRIETARY NAME: | miltefosine |
| SUBSTANCE NAME: | MILTEFOSINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antileishmanial [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-09-19 |
| END MARKETING DATE: | 0000-00-00 |
IMPAVIDO HUMAN PRESCRIPTION DRUG Details:
| Item Description | IMPAVIDO from Paladin Therapeutics Inc. |
| LABELER NAME: | Paladin Therapeutics Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2014-09-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61744-050_d6658aeb-7bc1-4eef-ad0d-0a873ddbecf5 |
| PRODUCT NDC: | 61744-050 |
| APPLICATION NUMBER: | NDA204684 |
Other MILTEFOSINE Pharmaceutical Manufacturers / Labelers:
